Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors

Completed · Not applicable

Conditions studied: Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm

In brief

This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negative outcomes such as poor quality of life, depression, distress, substance use, sleep problems, fatigue, and pain. ABM uses techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. ABM uses brief self-guided smartphone applications. Patients complete repetitive association reaction-time tasks targeting automatic and unconscious negative attention biases to retrain attention away from perceived threat and towards a neutral or positive stimuli. Gratitude-finding and savoring activities are also provided to maintain and increase positive emotions. Using ABM plus gratitude-finding and savoring activities may improve anxiety in AYA cancer survivors.

Key facts

Study ID

NCT06682039

Run by

Fred Hutchinson Cancer Center

People needed

70

Starts

2024-11-08

Expected to finish

2026-01-12

Last updated by the study team

2026-01-30

Who can join

Age: 15 and older, up to 29. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 15-29 years
• Diagnosis of cancer malignancy
• Received active/curative cancer treatment OR received/actively receiving cancer survivorship care at Seattle Children's Hospital (SCH) or other study referring site (e.g. St. Jude)
• Currently off active/curative cancer treatment
• Patient able to understand/read/write English language
• Cognitively able to participate in ABM intervention and complete surveys
• Patient has access to smartphone able to send and receive text messages
• Patient has access to computer or smartphone for Inquisit program

You may not qualify if…

• Patients on active/curative cancer treatment
• Cognitively or physically unable to participate in ABM intervention and surveys
• Patients who cannot understand/read/write English will be excluded from the research because the ABM intervention is currently only available in English
• Furthermore, patients who do not have access to technology (smartphone/computer) will be excluded from the study as this technology is absolutely required to engage in the study intervention

Where it is running

• Fred Hutch/University of Washington/Seattle Children's Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.